A new study finds that, for robots, overlords are less persuasive than peers
Megan Hall: AstraZeneca hopes to one day eliminate cancer as a cause of death.
That's why AstraZeneca started the YOUR Cancer program, an effort to work with the larger cancer community to create meaningful change in the treatment and care of people with cancer.
To learn more about these efforts, and AstraZeneca's cancer work in general, Scientific American Custom Media caught up with Chatrick Paul, the Head of US Oncology Business for AstraZeneca.
We are passionate about redefining cancer care, and one day eliminate cancer as a cause of death.
Paul: So we know that by bringing more effective and better-tolerated medicines, we play a major role in realizing our bold ambition here at AstraZeneca to one day eliminate cancer as a cause of death.
Can you talk more specifically about how AstraZeneca is working to further advance cancer treatment and care in other areas of the field of cancer?
According to the American Cancer Society, from 1991 to 2018, cancer death rates fell by 31%. What that tells me is that we are winning the war against cancer.
Hall: If you were to look 10 years into the future, what would you hope to be celebrating in terms of advancements in cancer treatment and care?
YOUR Cancer brings together the community that is working to drive meaningful change in cancer care.
For more remarkable stories from the 2021 Winners of the Cancer Community Awards, visit our Heroes of Cancer Care collection.